AI cancer startup collaborates with top Israeli hospital
Cloud platform enables whole genome sequencing from data derived from blood tests that can detect recurring cancer early on.
Cloud platform enables whole genome sequencing from data derived from blood tests that can detect recurring cancer early on.
Winners were selected by CB Insights’ Intelligence Unit from a pool of over 11,000 digital health companies globally.
A new genomic platform uses AI to enable doctors to find mutations signifying persistent or recurrent cancer cells months or years before current technologies.